Literature DB >> 9892452

Trends in infectious disease mortality in the United States during the 20th century.

G L Armstrong1, L A Conn, R W Pinner.   

Abstract

CONTEXT: Recent increases in infectious disease mortality and concern about emerging infections warrant an examination of longer-term trends.
OBJECTIVE: To describe trends in infectious disease mortality in the United States during the 20th century. DESIGN AND
SETTING: Descriptive study of infectious disease mortality in the United States. Deaths due to infectious diseases from 1900 to 1996 were tallied by using mortality tables. Trends in age-specific infectious disease mortality were examined by using age-specific death rates for 9 common infectious causes of death.
SUBJECTS: Persons who died in the United States between 1900 and 1996. MAIN OUTCOME MEASURES: Crude and age-adjusted mortality rates.
RESULTS: Infectious disease mortality declined during the first 8 decades of the 20th century from 797 deaths per 100000 in 1900 to 36 deaths per 100000 in 1980. From 1981 to 1995, the mortality rate increased to a peak of 63 deaths per 100000 in 1995 and declined to 59 deaths per 100000 in 1996. The decline was interrupted by a sharp spike in mortality caused by the 1918 influenza epidemic. From 1938 to 1952, the decline was particularly rapid, with mortality decreasing 8.2% per year. Pneumonia and influenza were responsible for the largest number of infectious disease deaths throughout the century. Tuberculosis caused almost as many deaths as pneumonia and influenza early in the century, but tuberculosis mortality dropped off sharply after 1945. Infectious disease mortality increased in the 1980s and early 1990s in persons aged 25 years and older and was mainly due to the emergence of the acquired immunodeficiency syndrome (AIDS) in 25- to 64-year-olds and, to a lesser degree, to increases in pneumonia and influenza deaths among persons aged 65 years and older. There was considerable year-to-year variability in infectious disease mortality, especially for the youngest and oldest age groups.
CONCLUSIONS: Although most of the 20th century has been marked by declining infectious disease mortality, substantial year-to-year variation as well as recent increases emphasize the dynamic nature of infectious diseases and the need for preparedness to address them.

Entities:  

Mesh:

Year:  1999        PMID: 9892452     DOI: 10.1001/jama.281.1.61

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  178 in total

Review 1.  Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics.

Authors:  Christine F Markwalter; Andrew G Kantor; Carson P Moore; Kelly A Richardson; David W Wright
Journal:  Chem Rev       Date:  2018-12-04       Impact factor: 60.622

2.  Can dexamethasone be useful in community-acquired pneumonia?

Authors:  Paola Fracasso; Giorgio Costantino
Journal:  Intern Emerg Med       Date:  2011-11-25       Impact factor: 3.397

3.  The time of cholera.

Authors:  David N Fisman; Kevin Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

4.  Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia.

Authors:  Jacobien J Hoogerwerf; Gerritje J W van der Windt; Dana C Blok; Arie J Hoogendijk; Alex F De Vos; Cornelis van 't Veer; Sandrine Florquin; Koichi S Kobayashi; Richard A Flavell; Tom van der Poll
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

5.  CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection.

Authors:  Junjie Mei; Yuhong Liu; Ning Dai; Michael Favara; Teshell Greene; Samithamby Jeyaseelan; Mortimer Poncz; Janet S Lee; G Scott Worthen
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

6.  The impact of global budgeting on health service utilization, health care expenditures, and quality of care among patients with pneumonia in Taiwan.

Authors:  C-Y Lin; T Ma; C-C Lin; C-H Kao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-02       Impact factor: 3.267

Review 7.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 8.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

9.  The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury.

Authors:  Hiroyuki Seki; Koichi Fukunaga; Makoto Arita; Hiroyuki Arai; Hiroki Nakanishi; Ryo Taguchi; Taku Miyasho; Rina Takamiya; Koichiro Asano; Akitoshi Ishizaka; Junzo Takeda; Bruce D Levy
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

Review 10.  Defining and predicting severe community-acquired pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Curr Opin Infect Dis       Date:  2010-04       Impact factor: 4.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.